These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 837641)

  • 1. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
    Ryan JR; Jain AK; McMahon FG; Vargas R
    Clin Pharmacol Ther; 1977 Feb; 21(2):231-3. PubMed ID: 837641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac.
    Green D; Ts'ao CH; Rossi EC
    Lancet; 1977 Apr; 1(8015):804. PubMed ID: 66601
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of diclofenac sodium on the metabolism of diabetics in qualitative diet therapy with an without tolbuamide. A clinically oriented study in aged diabetics with rheumatic disease].
    Schlumpf U
    Schweiz Med Wochenschr; 1978 Jan; 108(1):28-34. PubMed ID: 304247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac and gastric mucosa.
    Porro GB; Petrillo M; Caruso E; Fumagalli M
    Lancet; 1977 May; 1(8022):1152-3. PubMed ID: 68248
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function.
    Green D; Given KM; Ts'ao C; Whipple JP; Rossi EC
    Thromb Res; 1977 Feb; 10(2):283-9. PubMed ID: 322358
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical and biological studies on indomethacin, sulindac and their analogs.
    Shen TY; Winter CA
    Adv Drug Res; 1977; 12():90-245. PubMed ID: 343530
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics.
    Whiting B; Williams RL; Lorenzi M; Varady JC; Robins DS
    Br J Clin Pharmacol; 1981 Mar; 11(3):295-302. PubMed ID: 7213531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.
    Pfeifer MA; Halter JB; Beard JC; Porte D
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1256-62. PubMed ID: 7028776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of maturity-onset diabetes mellitus resistant to insulin but responsive to tolbutamide.
    Rendell M; Slevin D; Meltz G; Simpson J; Barquet A
    Ann Intern Med; 1979 Feb; 90(2):195-7. PubMed ID: 443652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indomethacin and sulindac on hydrochlorothiazide kinetics.
    Koopmans PP; Kateman WG; Tan Y; van Ginneken CA; Gribnau FW
    Clin Pharmacol Ther; 1985 Jun; 37(6):625-8. PubMed ID: 3891188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the biologically active form of sulindac.
    Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG
    J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction between naproxen and tolbutamide on metabolism in diabetics].
    Sachse G; Willms B; Becker R
    Arzneimittelforschung; 1979; 29(5):835-6. PubMed ID: 582983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetics.
    Redman DR; Prescott LF
    Diabetes; 1973 Mar; 22(3):210-1. PubMed ID: 4689295
    [No Abstract]   [Full Text] [Related]  

  • 17. Intestinal blood loss after a new anti-inflammatory drug, sulindac.
    Cohen A
    Clin Pharmacol Ther; 1976 Aug; 20(2):238-40. PubMed ID: 1084825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of tolbutamide on serum glucose level, specific activity of glucose and glucose oxidation in severe diabetes.
    Adlung J; Koch CD
    Int J Clin Pharmacol; 1974 Sep; 10(2):128-35. PubMed ID: 4448554
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M; Hansen JM
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.